These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28092205)

  • 21. Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam.
    Reich-Schupke S; Weyer K; Altmeyer P; Stücker M
    Vasa; 2010 May; 39(2):169-74. PubMed ID: 20464673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study".
    Hamel-Desnos C; Ouvry P; Benigni JP; Boitelle G; Schadeck M; Desnos P; Allaert FA
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):723-9; discussion 730. PubMed ID: 17884623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
    Star P; Connor DE; Parsi K
    Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polidocanol-foam treatment of varicose veins: Quality-of-life impact compared to conventional surgery.
    Sakugawa LS; Portela FSO; Louzada ACS; Portugal MFC; Teivelis MP; Mendes CA; Pinheiro LL; Silva MFAD; Fioranelli A; Wolosker N
    Clinics (Sao Paulo); 2024; 79():100346. PubMed ID: 38574572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results.
    Gonzalez-Zeh R; Armisen R; Barahona S
    J Vasc Surg; 2008 Oct; 48(4):940-6. PubMed ID: 18639418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.
    Frullini A; Cavezzi A
    Dermatol Surg; 2002 Jan; 28(1):11-5. PubMed ID: 11991262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the treatment of the small saphenous veins with foam sclerotherapy at risk of deep vein thrombosis?
    Gillet JL; Lausecker M; Sica M; Guedes JM; Allaert FA
    Phlebology; 2014 Oct; 29(9):600-7. PubMed ID: 23864534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-center experience with foam sclerotherapy without ultrasound guidance for treatment of varicose veins.
    Uurto I; Hannukainen J; Aarnio P
    Dermatol Surg; 2007 Nov; 33(11):1334-9; discussion 1339. PubMed ID: 17958585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catheter-directed foam sclerotherapy of great saphenous veins in combination with pre-treatment reduction of the diameter employing the principals of perivenous tumescent local anesthesia.
    Devereux N; Recke AL; Westermann L; Recke A; Kahle B
    Eur J Vasc Endovasc Surg; 2014 Feb; 47(2):187-95. PubMed ID: 24268395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invited Commentary re: Comparison of 1% and 3% Polidocanol Foam in Ultrasound Guided Sclerotherapy of the Great Saphenous Vein: A Randomised, Double-blind Trial with 2 Year-Follow-up. "The 3/1 Study".
    Cavezzi A
    Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):730. PubMed ID: 17888692
    [No Abstract]   [Full Text] [Related]  

  • 31. Prospective randomised comparative study of visual foam sclerotherapy alone or in combination with ultrasound-guided foam sclerotherapy for treatment of superficial venous insufficiency: preliminary report.
    Yamaki T; Hamahata A; Soejima K; Kono T; Nozaki M; Sakurai H
    Eur J Vasc Endovasc Surg; 2012 Mar; 43(3):343-7. PubMed ID: 22230599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
    Rabe E; Pannier F
    Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in venous function after foam sclerotherapy of varicose veins.
    Brunken A; Rabe E; Pannier F
    Phlebology; 2009 Aug; 24(4):145-50. PubMed ID: 19620696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polidocanol foam sclerotherapy of persisting postoperative seromas after varicose vein surgery: a series of six cases.
    Moritz RK; Reich-Schupke S; Altmeyer P; Stücker M
    Phlebology; 2013 Oct; 28(7):341-6. PubMed ID: 22865419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
    Cameron E
    Dermatol Surg; 2012 Feb; 38(2):290. PubMed ID: 22309639
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
    Bush R; Bush P
    Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant endothelin release in patients treated with foam sclerotherapy.
    Frullini A; Barsotti MC; Santoni T; Duranti E; Burchielli S; Di Stefano R
    Dermatol Surg; 2012 May; 38(5):741-7. PubMed ID: 22540861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures.
    King T; Coulomb G; Goldman A; Sheen V; McWilliams S; Guptan RC
    Int Angiol; 2009 Aug; 28(4):289-97. PubMed ID: 19648872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endovenous laser ablation and concomitant foam sclerotherapy: experience in 504 patients.
    Yilmaz S; Ceken K; Alparslan A; Durmaz S; Sindel T
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1403-7. PubMed ID: 22167308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt.
    Regan JD; Gibson KD; Rush JE; Shortell CK; Hirsch SA; Wright DD
    J Vasc Surg; 2011 Jan; 53(1):131-7. PubMed ID: 20864303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.